ALK and neuroblastoma: Of the neuroblastoma cell lines tested, both CLB-BAR and CLB-GE are dependent on ALK activity and responded as ALK-addicted cell lines in a manner similar to that previously shown for crizotinib (Schonherr et al., 2012).